Lobe Sciences Ltd.

Recent News

  • Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board

    Vancouver, British Columbia--(Newsfile Corp. - March 3, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Bart Oates Esq., President of the NFL Alumni Association, to its Advisory Board.Philip Young, CEO and Director of Lobe, stated, "We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and...

    2021-03-03 8:00 AM ET
  • Lobe Sciences to Present at Psychedelic Capital Virtual Investor Conference

    Vancouver, British Columbia--(Newsfile Corp. - February 24, 2021) -  Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at "The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference", a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.As a presenting sponsor, the Company will connect...

    2021-02-24 5:00 PM ET
  • Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.

    Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) -  Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF)  ("Lobe" or the "Company") and Ionic Brands Corp. ("Ionic Brands") are pleased to announce that, further to their press releases dated December 1, 2020, Lobe's wholly owned subsidiary Green Star Biosciences Inc. has signed a definitive binding asset purchase agreement dated February 22, 2021 (the "Agreement") with Ionic Brands with respect to the sale to Ionic Brands of certain assets held by Lobe's...

    2021-02-23 8:40 AM ET
  • Lobe Sciences to Present at Virtual One2One Investor Forum

    Vancouver, British Columbia--(Newsfile Corp. - February 22, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announces that Philip Young, CEO and Director, will be interviewed on Tuesday, February 23rd, 2021 at 1:00 pm EST by broadcast journalist Christine Corrado of Proactive Investors, a leading multi-media news organization, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt, and London.The Virtual One2One Investor Forum invitation will be sent to Proactive's...

    2021-02-22 8:00 AM ET
  • Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

    Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) -  Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announced today the completion and testing of the proof-of-concept prototype of its proprietary nasal mist device. As announced on December 3, 2020, the Company engaged VisionWorks Engineering of San Diego, CA to complete this first phase of development. Lobe's nasal mist device delivers "micro doses" of pharmaceutical agents such as a psilocybin and N-acetylcysteine ("NAC") at preselected dosages.Philip Young, CEO...

    2021-02-18 8:30 AM ET
  • Lobe Sciences Retains Jolt Communications to Increase Investor Awareness

    Vancouver, British Columbia--(Newsfile Corp. - February 12, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has retained Jolt Communications LLC ("Jolt") to lead its investor relations efforts.Philip Young, CEO of Lobe, states, "We are pleased to work with Jolt in an effort to bolster our communications with the investment community. We have a compelling story at Lobe and look forward to sharing it with the investment community...

    2021-02-12 5:00 PM ET
  • Lobe Sciences Announces Management Changes and New Director

    Vancouver, British Columbia--(Newsfile Corp. - January 18, 2021) -  Lobe Sciences Ltd (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Mr. Philip J. Young as Chief Executive Officer, Corporate Secretary and a director of the Company, effective January 15, 2021. Mr. Young replaces Thomas Baird, who resigned as CEO as of the same date. Philip Young is an accomplished CEO and innovative professional with 25 years of expertise in senior executive...

    2021-01-18 7:45 AM ET
  • Lobe Sciences Announces Changes to Board of Directors

    Vancouver, British Columbia--(Newsfile Corp. - January 8, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Mr. Michael Petter as an independent director to the Company's Board of Directors, effective immediately. Mr. Petter replaces Thomas Baird, who resigned from the Company's Board of Directors effective today, but still remains CEO of the Company.Michael Petter is an accomplished leader and entrepreneur with significant experience in the psychedelics...

    2021-01-08 6:00 PM ET